BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25593079)

  • 1. Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety.
    Zali A; Arab L; Ashrafi F; Mardpour S; Niknejhadi M; Hedayati-Asl AA; Halimi-Asl A; Ommi D; Hosseini SE; Baharvand H; Aghdami N
    Cytotherapy; 2015 Feb; 17(2):232-41. PubMed ID: 25593079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in gross motor function and muscle tone in children with cerebral palsy related to neonatal icterus: an open-label, uncontrolled clinical trial.
    Thanh LN; Trung KN; Duy CV; Van DN; Hoang PN; Phuong ANT; Ngo MD; Thi TN; Viet AB
    BMC Pediatr; 2019 Aug; 19(1):290. PubMed ID: 31438885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study.
    Wang X; Cheng H; Hua R; Yang J; Dai G; Zhang Z; Wang R; Qin C; An Y
    Cytotherapy; 2013 Dec; 15(12):1549-62. PubMed ID: 24100132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors.
    Wang X; Hu H; Hua R; Yang J; Zheng P; Niu X; Cheng H; Dai G; Liu X; Zhang Z; An Y
    Cytotherapy; 2015 Feb; 17(2):224-31. PubMed ID: 25593078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy.
    Nguyen TL; Nguyen HP; Nguyen TK
    Health Qual Life Outcomes; 2018 Aug; 16(1):164. PubMed ID: 30107811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy.
    Liu X; Fu X; Dai G; Wang X; Zhang Z; Cheng H; Zheng P; An Y
    J Transl Med; 2017 Feb; 15(1):48. PubMed ID: 28235424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.
    Mancías-Guerra C; Marroquín-Escamilla AR; González-Llano O; Villarreal-Martínez L; Jaime-Pérez JC; García-Rodríguez F; Valdés-Burnes SL; Rodríguez-Romo LN; Barrera-Morales DC; Sánchez-Hernández JJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Gómez-De León A; Elizondo-Riojas G; Salazar-Riojas R; Gómez-Almaguer D
    Cytotherapy; 2014 Jun; 16(6):810-20. PubMed ID: 24642016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.
    Suzuki G; Iyer V; Lee TC; Canty JM
    Circ Res; 2011 Oct; 109(9):1044-54. PubMed ID: 21885831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
    Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
    Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
    Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
    BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vibration therapy on spasticity and motor function in children with cerebral palsy: a randomized controlled trial.
    Katusic A; Alimovic S; Mejaski-Bosnjak V
    NeuroRehabilitation; 2013; 32(1):1-8. PubMed ID: 23422453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
    Harris VK; Vyshkina T; Sadiq SA
    Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with autologous M2 macrophages in children with severe cerebral palsy.
    Chernykh ER; Kafanova MY; Shevela EY; Sirota SI; Adonina EI; Sakhno LV; Ostanin AA; Kozlov VV
    Cell Transplant; 2014; 23 Suppl 1():S97-104. PubMed ID: 25302537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROSPECTIVE SINGLE CENTER ANALYSIS OF OUTCOME STEM CELLS TRANSPLANTS IN PATIENTS WITH CEREBRAL PALSY.
    Yousif NG; Yousif MG; Mohsen AAU; El-Bakaa HS; Younise MH; Altimimi AN; Nöth UA; Hassan AM
    Pol Merkur Lekarski; 2023; 51(4):339-345. PubMed ID: 37756453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between spasticity and gross motor capability in nonambulatory children with spastic cerebral palsy.
    Katusic A; Alimovic S
    Int J Rehabil Res; 2013 Sep; 36(3):205-10. PubMed ID: 23282668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial.
    Amanat M; Majmaa A; Zarrabi M; Nouri M; Akbari MG; Moaiedi AR; Ghaemi O; Zamani F; Najafi S; Badv RS; Vosough M; Hamidieh AA; Salehi M; Montazerlotfelahi H; Tavasoli AR; Heidari M; Mohebi H; Fatemi A; Garakani A; Ashrafi MR
    Stem Cell Res Ther; 2021 Aug; 12(1):439. PubMed ID: 34362453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy.
    Pozzobon M; Piccoli M; Ditadi A; Bollini S; Destro R; André-Schmutz I; Masiero L; Lenzini E; Zanesco L; Petrelli L; Cavazzana-Calvo M; Gazzola MV; De Coppi P
    Stem Cells Dev; 2009 Apr; 18(3):497-510. PubMed ID: 18598159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bone marrow-derived CD133(+) cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis.
    Pozzobon M; Bollini S; Iop L; De Gaspari P; Chiavegato A; Rossi CA; Giuliani S; Fascetti Leon F; Elvassore N; Sartore S; De Coppi P
    Cell Transplant; 2010; 19(10):1247-60. PubMed ID: 20447342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
    Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
    J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.